Anti-Inflammatory and Anti-Fibrotic Effects of Thymosin Beta4 Fragment Ac-SDKP. - Ai-Peptides

FREE SHIPPING ON ORDERS OVER $100

Research Categories
Research Categories
More
Research Categories

Peptide Sciences Research

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.

Anti-Inflammatory and Anti-Fibrotic Effects of Thymosin Beta4 Fragment Ac-SDKP.

Ac-SDKP is a Peptide Fragment of Thymosin Beta 4 (TB-500)

“Tβ4 is a naturally occurring peptide consisting of 43 base pairs of amino acids and generates the N-terminal tetrapeptide AcSDKP.” (14)

Peptide Ac-SDKP was isolated from the whole Thymosin Beta 4 Peptide Sequence.

Ac-SDKP Reduced Kidney Fibrosis.

“Treatment of cultured cells with ACEi alone or in combination with AcSDKP prevented the downregulated expression of miR-29s and miR-let-7s induced by TGFβ stimulation. Interestingly, ACEi also restored miR-29 and miR-let-7 family cross-talk in endothelial cells, an effect that is shared by AcSDKP suggesting that AcSDKP may be partially involved in the anti-mesenchymal action of ACEi. The results of the present study promise to advance our understanding of how ACEi regulates antifibrotic microRNAs crosstalk and DPP-4 associated-fibrogenic processes which is a critical event in the development of diabetic kidney disease.” (14)

Be the first to know

Receive all the latest information on events, sales, & offers.

Welcome back!

or
Menu
Explore

Search Peptides

Welcome back!

or
0